PTHS

Pelthos Therapeutics Inc. AMEX Listed Jul 2, 2025

Healthcare ·Biotechnology ·US · pelthos.com

$25.91

After hrs $27.60 +1.32%

Mkt Cap $16.8M

52w Low $9.00 37.3% of range 52w High $54.29

50d MA $23.30 200d MA $25.77

P/E (TTM) -1.1x

EV/EBITDA -2.5x

P/B 1.2x

Debt/Equity 0.9x

ROE -111.4%

P/FCF -2.6x

RSI (14) —

ATR (14) —

Beta 3.99

50d MA $23.30

200d MA $25.77

Avg Volume 8.7K

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

SIC Code

2836

CIK (SEC)

1919246

Phone

877 265 8266

4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703 · Durham, NC 27703 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 19, 2026	AMC	-3.95	-2.83	+28.4%	22.97	-1.9%	-9.7%	+6.1%	+0.0%	+0.4%	+2.9%	—
Nov 13, 2025	AMC	-0.67	-5.30	-691.0%	34.68	-4.8%	-3.1%	-0.9%	-4.4%	-5.7%	-3.4%	—
Aug 13, 2025	AMC	-3.10	-5.38	-73.5%	18.18	+2.3%	+4.3%	+10.5%	+1.4%	-3.5%	+4.4%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 20	Oppenheimer	Maintains	Outperform → Outperform	—	$22.97	$22.54	-1.9%	-9.7%	+6.1%	+0.0%	+0.4%	+2.9%
Mar 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$24.08	$24.95	+3.6%	-4.6%	-9.7%	+6.1%	+0.0%	+0.4%
Feb 26	Roth Capital	Maintains	Buy → Buy	—	$23.00	$23.00	+0.0%	+0.0%	+14.6%	-8.3%	+0.1%	-4.9%
Jan 26	Oppenheimer	Maintains	Outperform → Outperform	—	$24.75	$24.52	-0.9%	-0.9%	+5.6%	-4.6%	+4.4%	-6.8%
Nov 14	Oppenheimer	Maintains	Outperform → Outperform	—	$34.68	$33.00	-4.8%	-3.1%	-0.9%	-4.4%	-5.7%	-3.4%

Data updated apr 26, 2026 9:09pm · Source: massive.com